INmune Bio, Inc.
General ticker "INMB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $56.9M (TTM average)
INmune Bio, Inc. follows the US Stock Market performance with the rate: 32.3%.
Estimated limits based on current volatility of 3.6%: low 2.23$, high 2.39$
Factors to consider:
- Total employees count: 21 as of 2025
- Top business risk factors: Going concern doubt, Losses/no profitability, Capital raising, Regulatory and compliance, Product liability
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.93$, 3.25$]
- 2026-12-31 to 2027-12-31 estimated range: [1.21$, 3.81$]
Financial Metrics affecting the INMB estimates:
- Positive: with PPE of -0.9 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -49.97 <= 0.28
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: -4.49 < Investing cash flow per share per price, % of -2.31
Short-term INMB quotes
Long-term INMB plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.15MM | $0.01MM | $0.05MM |
| Operating Expenses | $29.90MM | $42.65MM | $47.43MM |
| Operating Income | $-29.74MM | $-42.63MM | $-47.38MM |
| Non-Operating Income | $-0.27MM | $0.55MM | $1.45MM |
| R&D Expense | $20.27MM | $33.17MM | $20.66MM |
| Income(Loss) | $-30.01MM | $-42.08MM | $-45.93MM |
| Net Income(Loss)* | $-30.01MM | $-42.08MM | $-45.93MM |
| Stockholders Equity | $37.34MM | $32.10MM | $23.52MM |
| Assets | $57.00MM | $39.56MM | $32.35MM |
| Operating Cash Flow | $-11.98MM | $-33.36MM | $-22.58MM |
| Capital expenditure | $0.00MM | $0.00MM | $1.04MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-1.04MM |
| Financing Cash Flow | $-4.22MM | $18.21MM | $27.61MM |
| Earnings Per Share** | $-1.67 | $-2.11 | $-1.73 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.